Ceredex Value Advisors’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15M Buy
101,880
+39,576
+64% +$6.43M 0.47% 93
2025
Q4
$12.1M Buy
+62,304
New +$14.8M 0.37% 132
2018
Q3
Sell
-1,725,841
Closed -$76M 186
2018
Q2
$76M Sell
1,725,841
-716,271
-29% -$33M 0.87% 43
2018
Q1
$112M Buy
+2,442,112
New +$121M 1.33% 4

Other funds holding ORCL

Ceredex Value Advisors's ORCL Position: Q1 2026 in Review

Ceredex Value Advisors increased its Oracle (ORCL) stake by 64% in Q1 2026, buying an estimated $6.43M and bringing the position to 101,880 shares worth $15M. The position accounts for 0.47% of the portfolio, ranked #93.

Ceredex Value Advisors first reported a position in ORCL in Q1 2018 and has held it in 4 quarters since. The position peaked at $112M in Q1 2018. 3,474 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Ceredex Value Advisors held 101,880 shares of Oracle worth $15M as of Q1 2026.
  • Ceredex Value Advisors bought 39,576 Oracle shares in Q1 2026, an estimated $6.43M.
  • Oracle made up 0.47% of Ceredex Value Advisors's portfolio in Q1 2026, its #93 holding.
  • Ceredex Value Advisors first reported a position in Oracle in Q1 2018 and has held it in 4 quarters since.
  • Ceredex Value Advisors's Oracle position peaked at $112M in Q1 2018.
  • 3,474 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Ceredex Value Advisors's 13F filing for Q1 2026, filed 14 May 2026.